233 related articles for article (PubMed ID: 10557082)
1. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2.
Fachinger G; Deutsch U; Risau W
Oncogene; 1999 Oct; 18(43):5948-53. PubMed ID: 10557082
[TBL] [Abstract][Full Text] [Related]
2. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.
Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D
EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928
[TBL] [Abstract][Full Text] [Related]
3. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.
Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D
Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368
[TBL] [Abstract][Full Text] [Related]
4. VE-PTP controls blood vessel development by balancing Tie-2 activity.
Winderlich M; Keller L; Cagna G; Broermann A; Kamenyeva O; Kiefer F; Deutsch U; Nottebaum AF; Vestweber D
J Cell Biol; 2009 May; 185(4):657-71. PubMed ID: 19451274
[TBL] [Abstract][Full Text] [Related]
5. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation.
Hayashi M; Majumdar A; Li X; Adler J; Sun Z; Vertuani S; Hellberg C; Mellberg S; Koch S; Dimberg A; Koh GY; Dejana E; Belting HG; Affolter M; Thurston G; Holmgren L; Vestweber D; Claesson-Welsh L
Nat Commun; 2013; 4():1672. PubMed ID: 23575676
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease.
Carr AN; Davis MG; Eby-Wilkens E; Howard BW; Towne BA; Dufresne TE; Peters KG
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H268-76. PubMed ID: 14988069
[TBL] [Abstract][Full Text] [Related]
7. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
[TBL] [Abstract][Full Text] [Related]
8. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.
Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D
J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature.
Takahashi K; Kim R; Lauhan C; Park Y; Nguyen NG; Vestweber D; Dominguez MG; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gale NW; Takahashi T
PLoS One; 2017; 12(5):e0177192. PubMed ID: 28542220
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development.
Bäumer S; Keller L; Holtmann A; Funke R; August B; Gamp A; Wolburg H; Wolburg-Buchholz K; Deutsch U; Vestweber D
Blood; 2006 Jun; 107(12):4754-62. PubMed ID: 16514057
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase.
Yang Y; Gil MC; Choi EY; Park SH; Pyun KH; Ha H
Gene; 1997 Feb; 186(1):77-82. PubMed ID: 9047348
[TBL] [Abstract][Full Text] [Related]
12. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations.
Uranishi R; Baev NI; Ng PY; Kim JH; Awad IA
Neurosurgery; 2001 Feb; 48(2):359-67; discussion 367-8. PubMed ID: 11220380
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis.
Dominguez MG; Hughes VC; Pan L; Simmons M; Daly C; Anderson K; Noguera-Troise I; Murphy AJ; Valenzuela DM; Davis S; Thurston G; Yancopoulos GD; Gale NW
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3243-8. PubMed ID: 17360632
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
15. Activation of Angiopoietin-Tie2 Signaling Protects the Kidney from Ischemic Injury by Modulation of Endothelial-Specific Pathways.
Li Y; Liu P; Zhou Y; Maekawa H; Silva JB; Ansari MJ; Boubes K; Alia Y; Deb DK; Thomson BR; Jin J; Quaggin SE
J Am Soc Nephrol; 2023 Jun; 34(6):969-987. PubMed ID: 36787763
[TBL] [Abstract][Full Text] [Related]
16. Shear stress-induced redistribution of vascular endothelial-protein-tyrosine phosphatase (VE-PTP) in endothelial cells and its role in cell elongation.
Mantilidewi KI; Murata Y; Mori M; Otsubo C; Kotani T; Kusakari S; Ohnishi H; Matozaki T
J Biol Chem; 2014 Mar; 289(10):6451-6461. PubMed ID: 24451369
[TBL] [Abstract][Full Text] [Related]
17. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase.
Huang L; Turck CW; Rao P; Peters KG
Oncogene; 1995 Nov; 11(10):2097-103. PubMed ID: 7478529
[TBL] [Abstract][Full Text] [Related]
18. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
19. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
